Related Experiment Video
Updated: Jun 17, 2025

08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.0K
[Role of Neurologists in Dementia Practice]
1Department of Behavioral Neurology and Neuropsychiatry, Osaka University.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|August 8, 2024
Summary
Neurologists are increasingly vital in dementia care, especially with new treatments like lecanemab. Enhancing behavioral neurology expertise is crucial to meet Japan's growing need for dementia specialists.
Area of Science:
- Neurology
- Geriatrics
- Public Health
Background:
- Neurologists play a key role in dementia care, collaborating within interdisciplinary teams.
- Recent advancements, including the anti-Alzheimer drug lecanemab and the Basic Act on Dementia, necessitate expanded neurologist involvement.
- A significant shortage of behavioral neurologists exists in Japan, impacting dementia management.
Purpose of the Study:
- To highlight the evolving role of neurologists in dementia practice.
- To emphasize the need for specialized skills in behavioral neurology for effective dementia management.
- To address the critical shortage of dementia specialists in Japan.
Main Methods:
- Review of the current landscape of dementia care and neurologist contributions.
- Analysis of the impact of lecanemab on neurologist involvement in dementia practice.
- Discussion of educational gaps in behavioral neurology for general neurologists.
Main Results:
- The introduction of lecanemab has increased neurologist engagement in dementia care, creating "novice" specialists.
- Inadequate training in behavioral neurology hinders effective dementia management by general neurologists.
- A critical shortage of specialized behavioral neurologists persists in Japan.
Conclusions:
- Neurologists must transition from "novice" to expert status in dementia care.
- Urgent action is required to address the shortage of behavioral neurologists.
- Enhanced education and specialized training are essential for neurologists in dementia management.
Related Concept Videos
Dementia
108
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
108
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K

